1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Novel stool-based protein biomarkers for improved colorectal cancer screening : a case-control study
- Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
- 2016
- WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy
- 2013
- Association of DNA promoter hypermethylation of decoy receptor 1 (DCR1) with poor response to irinotecan in metastatic colorectal cancer
- 2012
- Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
- DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT
- Genome‐wide RNA‐ and MBD‐sequencing in HCT116 and DKO cells as a global re‐expression model
- An omnibus consistent adaptive percentile modified Wilcoxon rank sum test with applications in gene expression studies
- 2009
- Promoter hypermethylation of Phactr3, a potential new biomarker for colorectal cancer detection
- Promoter DNA methylation of Oncostatin M receptor-β as a novel diagnostic and therapeutic marker in colon cancer